Breaking News
Sort by:
Top Post
Roche’s Tecentriq Plus Avastin Reduced Risk of Cancer Returning in People with Certain Types of Adjuvant Liver Cancer in a Phase III Study
Roche has announced new data from the Phase III IMbrave050 study that show Tecentriq (atezolizumab) […]
Vial Announces the Addition of Dr. Marc Hoffmann from the University of Kansas Medical Center to their Oncology CRO Scientific Advisory Board
Vial, a tech-enabled CRO providing next-generation clinical trial management services, announced the addition of Marc Hoffmann, […]
Chinese NMPA Approves Study of Telix Kidney Cancer Imaging Candidate
Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the Chinese National Medical Products […]
Pheon Therapeutics Launches with $68 Million in Financing to Advance Novel Antibody-Drug Conjugates for Treatment of Solid Tumors
Pheon Therapeutics (Pheon), a leading Antibody-Drug Conjugate (ADC) specialist developing next generation ADCs for a wide […]
Thermo Fisher Scientific Announces FDA Approval of Oncomine Dx Target Test as the First NGS-Based Companion Diagnostic to Aid in Therapy Selection for Patients with RET Mutations/Fusions in Thyroid Cancers
The U.S. Food and Drug Administration (FDA) has granted approval to Thermo Fisher Scientific’s Oncomine Dx […]
CellOrigin Biotech Announces Global Strategic Collaboration with Qilu Pharma to Develop "Off-the-Shelf" CAR-iMAC Cell Therapy
CellOrigin Biotech (Hangzhou) Co., Ltd. announced it has made a global strategic collaboration agreement with […]
Aberdeen Dermatology Associates Is First in South Dakota to Offer Non-Surgical Technology for Treating Common Skin Cancers
SkinCure Oncology, the world leader in providing a comprehensive model for the delivery of Image-Guided […]
Breakthrough RNA-based Anti-CancerImmunotherapy Treatments Being Developed by Global Consortium Led by the Hadassah Cancer Research Institute
The Hadassah Cancer Research Institute (HCRI) at the Hadassah University Medical Center in Jerusalem, announced today […]
Ratio Therapeutics Appoints Jacob Hesterman, Ph.D., as Chief Data Officer
Ratio Therapeutics Inc., a pharmaceutical company that employs a suite of innovative technologies to develop […]
Strata Oncology Announces Expansion of Clinical Collaboration with Pfizer for Strata PATH Trial into Early-Stage Cancer
Strata Oncology, Inc. a next-generation precision oncology company enabling smarter and earlier cancer treatment, today […]
Vyriad, Inc. Appoints Scott Beck as Chief Operating Officer
Vyriad, Inc., a biotechnology company developing oncolytic virus therapies to treat a wide range of […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more